3,308
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Correlation between Micronutrient plasma concentration and disease severity in COVID-19 patients

ORCID Icon, , , , &
Pages 21-27 | Received 26 Sep 2020, Accepted 26 Dec 2020, Published online: 18 Jan 2021

Figures & data

Table 1. Baseline characteristics of patients

Table 2. Mean levels of some lab tests among patients diagnosed with severe and non-severe symptoms of COVID-19

Table 3. Mean serum levels of copper, ferritin, selenium, and zinc among patients diagnosed with severe and non-severe symptoms of COVID-19

Figure 1. Mean serum level of copper among patients diagnosed with severe and non-severe symptoms of COVID-19. * Normal range of copper in blood serum: 10–22 mcmol/L

Figure 1. Mean serum level of copper among patients diagnosed with severe and non-severe symptoms of COVID-19. * Normal range of copper in blood serum: 10–22 mcmol/L

Figure 2. Mean serum level of zinc among patients diagnosed with severe and non-severe symptoms of COVID-19. * Normal range of zinc in blood serum: 66–110 mcg/dl

Figure 2. Mean serum level of zinc among patients diagnosed with severe and non-severe symptoms of COVID-19. * Normal range of zinc in blood serum: 66–110 mcg/dl

Figure 3. Mean serum level of selenium among patients diagnosed with severe and non-severe symptoms of COVID-19. * Normal range of selenium in blood serum: 70–150 mcg/L

Figure 3. Mean serum level of selenium among patients diagnosed with severe and non-severe symptoms of COVID-19. * Normal range of selenium in blood serum: 70–150 mcg/L

Figure 4. Mean serum level of ferritin among patients diagnosed with severe and non-severe symptoms of COVID-19. * Normal range of ferritin in blood serum: 12–300 ng/ml

Figure 4. Mean serum level of ferritin among patients diagnosed with severe and non-severe symptoms of COVID-19. * Normal range of ferritin in blood serum: 12–300 ng/ml

Figure 5. Ferritin metabolism and pathway in causing multi-organ inflammation and damage

Figure 5. Ferritin metabolism and pathway in causing multi-organ inflammation and damage

Figure 6. Products generated by free iron elements and drugs (deferoxamine, deferasirox or deferiprone) inhibiting its pathways. *ROS: Reactive Oxygen Species

Figure 6. Products generated by free iron elements and drugs (deferoxamine, deferasirox or deferiprone) inhibiting its pathways. *ROS: Reactive Oxygen Species

Figure 7. Products generated by free selenium elements and drug (deferiprone) inhibiting its pathways

Figure 7. Products generated by free selenium elements and drug (deferiprone) inhibiting its pathways